[{"Assets_0_Q3_USD":19953380000.0,"EarningsPerShareBasic_1_Q3_USD":131.75,"EarningsPerShareBasic_3_Q3_USD":195.29,"EarningsPerShareDiluted_1_Q3_USD":129.96,"EarningsPerShareDiluted_3_Q3_USD":192.76,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":498597000.0,"NetIncomeLossConverted_3_Q3_USD":5819561000.0,"NetIncomeLossConverted_1_Q3_USD":3928033000.0,"RevenuesConverted_1_Q3_USD":747049000.0,"RevenuesConverted_3_Q3_USD":2189776000.0,"StockholdersEquity_0_Q3_USD":15332378000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30190000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":30224000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29814000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20211029"}]